SpaceWar.com - Your World At War
UK's Porton Down military site is pioneer in chemicals research
London, March 7 (AFP) Mar 07, 2018
The British military facility in Porton Down analysing the nerve agent used in the poisoning of a former Russian double agent serves as a state-of-the-art laboratory specialising in chemical and biological weapons research.

Located just a few miles from Salisbury, the southwestern English city where Sergei Skripal, 66, and his 33-year-old daughter were targeted, is Britain's most secretive and controversial military base.

The Defence Science and Technology Laboratory -- its official name -- employs 3,000 scientists across a sprawling rural site, and has an annual budget of pound500 million (560 million euros, $695 million).

It was founded in 1916 to counter German gas attacks in World War I, which initially involved chlorine and then mustard gas and phosgene.

In the 1950s scientists at Porton Down developed non-lethal CS gas, better known as tear gas, as well as the deadly nerve agent VX, according to the BBC.

Given international conventions that prohibit the use of chemical weapons, research conducted at Porton Down is defensive in nature, Britain's Ministry of Defence (MoD) says.

The facility aims only to improve equipment and testing to protect troops and the population, it adds.

In recent years, the laboratory has participated in Ebola research, and has been involved in the fight against the epidemic in Sierra Leone since 2013.

It has also analysed the use of chemical weapons in the Syrian conflict, in particular sarin gas, the British government has previously revealed.

The long history of secrecy surrounding the site and its work has fueled persistent rumours and conspiracies, including accusations of experiments on animals and humans.

In 1999, police opened a probe into testing that may have endangered the life of soldiers without their knowledge.

The investigation did not result in criminal prosecutions, but in 2008 the MoD awarded 360 former members of the armed forces members compensation of pound3 million (3.4 million euros, $4.2 million).

They claimed to have served against their will as guinea pigs in Cold War era chemical testing, but the ministry did not admit responsibility.

In a June 2016 press release -- entitled "the truth about Porton Down" -- the MoD tried to rebut some of the claims about the site, including that aliens had been taken there and that it had been used to cultivate cannabis.

It outlined the work carried out at the facility, admitting successful testing "could not, currently, be achieved without the use of animals".

The laboratory also elaborated on its volunteer programme, which has seen 20,000 people take part in studies over the decades.

"(It) has always been operated to the highest ethical standards of the day," the MoD said.

apz/jj/je

CS COMMUNICATION & SYSTEMES


ADVERTISEMENT




Space News from SpaceDaily.com
Maven stays silent after routine pass behind Mars
Sun boundary map tracks shifting Alfven surface over solar cycle
Mission Space to fly second space weather payload with Rogue Space

24/7 Energy News Coverage
Molecular contacts push tandem solar cells to 31.4 percent efficiency
Asymmetric side chain design boosts thick film organic solar cell efficiency
New analysis links lead cooled reactor corrosion to steel microstructure

Military Space News, Nuclear Weapons, Missile Defense
Autonomous DARPA project to expand satellite surveillance network by BAE Systems
Momentus joins US Space Force SHIELD contract vehicle
IAEA calls for repair work on Chernobyl sarcophagus

24/7 News Coverage
UAlbany Atmospheric Scientist Proposes Innovative Method to Reduce Aviation's Climate Impact
Digital twin successfully launched and deployed into space
Robots that spare warehouse workers the heavy lifting



All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.